Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply

Aliment Pharmacol Ther. 2020 Nov;52(10):1621. doi: 10.1111/apt.16113.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Mesalamine*

Substances

  • Mesalamine